![[Publication] CDDF’s Meeting Report – Histology Independent Drug Development: Is This Future for Cancer Drugs?](https://cddf.org/wp-content/uploads/2023/01/Nov-Workshop_Meeting-Report_Social-Media.jpg)
[Publication] CDDF’s Meeting Report – Histology Independent Drug Development: Is This Future for Cancer Drugs?
The CDDF’s meeting report from its multi-stakeholder workshop on Histology independent drug development (Nov 2022, NL) has been published today. Discover thought-provoking key takeaways from the interesting sessions and share your thoughts with the CDDF community. To...
Season’s Greetings & Happy Holiday Wishe
🔔⛄ Season’s Greetings & Happy Holiday Wishes from the CDDF to all cancer patients, their families, and our stakeholders: In warm appreciation of your support and engagement with the CDDF during the past year, the CDDF extends our very best wishes for a Happy...
New Publication: Prof. Mark Lawler (CDDF Board) & his colleagues – the Lancet Oncology European Groundshot Commission on cancer research
Prof. Mark Lawler (CDDF Board) & his colleagues in the Lancet Oncology European Groundshot Commission on cancer research have published an insightful article on 16 November 2022. The European Groundshot—addressing Europe’s cancer research challenges: a Lancet...